NELIN injection is indicated in the treatment of infections caused by susceptible strains of the previously mentioned microorganism. Clinical studies have shown NELIN to be effective in: Bacteremia, septicemia; Serious infections of the respiratory tract; Kidney and genitourinary tract infections; Skin, soft tissue infections; Bone, joint infections; Burns, wounds, peri-operative infections; Intra-abdominal infection (including peritonitis); Infections of gastrointestinal tract; Infections of central nervous system (including meningitis).
NELIN injection is recommended as initial therapy in suspected or confirmed gram-negative infection. In serious infections when the causative organisms are unknown. NELIN injection may be administered as initial therapy in conjunction with a penicillin or cephalosporin type drug before, obtaining results of susceptibility testing. If anaerobic organisms are suspected suitable anti-microbial therapy in conjunction with NELIN injection should be given. Following identification of the organism and its susceptibility, NELIN injection or other appropriate antibiotic therapy should then be continued.